MICHAEL WHITE: Open Payments
NPI 1609851708 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 52 payments from 18 companies in 2025. Trend: 2023 $580 · 2024 $880 · 2025 $1,230
Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $463 |
| GlaxoSmithKline, LLC. | 10 | $149 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| Amgen Inc. | 3 | $56 |
| Astellas Pharma US Inc | 3 | $51 |
| PFIZER INC. | 3 | $50 |
| Lilly USA, LLC | 3 | $46 |
| ABBVIE INC. | 2 | $45 |
| Dexcom, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $32 |
Products named: Ozempic, ABILIFY MAINTENA, Rybelsus, TRELEGY ELLIPTA, Veozah, AREXVY, Dexcom G6 Transmitter, Auvelity.
Industry payments across MI — which companies pay providers there.
